Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-catechin | multiple interactions | ISO | TBC1D9B (Homo sapiens) | 6480464 | [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of TBC1D9B mRNA | CTD | PMID:24763279 | (1->4)-beta-D-glucan | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TBC1D9B mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of TBC1D9B mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | increases expression | EXP | | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of TBC1D9B mRNA | CTD | PMID:22206623 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of TBC1D9B mRNA | CTD | PMID:21570461 | 3,3',5,5'-tetrabromobisphenol A | increases expression | ISO | TBC1D9B (Homo sapiens) | 6480464 | tetrabromobisphenol A results in increased expression of TBC1D9B protein | CTD | PMID:31675489 | 3,4-methylenedioxymethamphetamine | increases expression | EXP | | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of TBC1D9B mRNA | CTD | PMID:20188158 | 3-chloropropane-1,2-diol | increases expression | ISO | Tbc1d9b (Rattus norvegicus) | 6480464 | alpha-Chlorohydrin results in increased expression of TBC1D9B protein | CTD | PMID:34915118 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | TBC1D9B (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of TBC1D9B mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | TBC1D9B (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of TBC1D9B mRNA | CTD | PMID:28628672 | acrolein | multiple interactions | ISO | TBC1D9B (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TBC1D9B mRNA more ... | CTD | PMID:32699268 and PMID:32845096 | aflatoxin B1 | increases methylation | ISO | TBC1D9B (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of TBC1D9B intron | CTD | PMID:30157460 | alpha-pinene | multiple interactions | ISO | TBC1D9B (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TBC1D9B mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TBC1D9B mRNA | CTD | PMID:32699268 | benzo[a]pyrene | increases expression | ISO | TBC1D9B (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of TBC1D9B mRNA | CTD | PMID:26238291 | bisphenol A | decreases expression | ISO | TBC1D9B (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of TBC1D9B mRNA and bisphenol A results in decreased expression of TBC1D9B protein | CTD | PMID:25047013 and PMID:31675489 | bisphenol A | decreases expression | ISO | Tbc1d9b (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of TBC1D9B mRNA | CTD | PMID:30816183 more ... | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of TBC1D9B mRNA | CTD | PMID:26063408 | cadmium dichloride | increases methylation | ISO | Tbc1d9b (Rattus norvegicus) | 6480464 | Cadmium Chloride results in increased methylation of TBC1D9B promoter | CTD | PMID:22457795 | cadmium dichloride | increases expression | ISO | Tbc1d9b (Rattus norvegicus) | 6480464 | Cadmium Chloride results in increased expression of TBC1D9B mRNA | CTD | PMID:33453195 | caffeine | increases phosphorylation | ISO | TBC1D9B (Homo sapiens) | 6480464 | Caffeine results in increased phosphorylation of TBC1D9B protein | CTD | PMID:35688186 | carbon nanotube | decreases expression | EXP | | 6480464 | Nanotubes and Carbon results in decreased expression of TBC1D9B mRNA | CTD | PMID:25620056 | copper(II) sulfate | decreases expression | ISO | TBC1D9B (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of TBC1D9B mRNA | CTD | PMID:19549813 | coumarin | increases phosphorylation | ISO | TBC1D9B (Homo sapiens) | 6480464 | coumarin results in increased phosphorylation of TBC1D9B protein | CTD | PMID:35688186 | crocidolite asbestos | decreases expression | EXP | | 6480464 | Asbestos and Crocidolite results in decreased expression of TBC1D9B mRNA | CTD | PMID:29279043 | CU-O LINKAGE | decreases expression | ISO | TBC1D9B (Homo sapiens) | 6480464 | cupric oxide results in decreased expression of TBC1D9B mRNA | CTD | PMID:22077320 | deguelin | decreases expression | ISO | TBC1D9B (Homo sapiens) | 6480464 | deguelin results in decreased expression of TBC1D9B mRNA | CTD | PMID:33512557 | dexamethasone | multiple interactions | ISO | TBC1D9B (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of TBC1D9B mRNA | CTD | PMID:28628672 | dibutyl phthalate | decreases expression | ISO | Tbc1d9b (Rattus norvegicus) | 6480464 | Dibutyl Phthalate results in decreased expression of TBC1D9B mRNA | CTD | PMID:21266533 | disodium selenite | increases expression | ISO | TBC1D9B (Homo sapiens) | 6480464 | Sodium Selenite results in increased expression of TBC1D9B mRNA | CTD | PMID:18175754 | elemental selenium | multiple interactions | ISO | TBC1D9B (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of TBC1D9B mRNA | CTD | PMID:19244175 | elemental selenium | increases expression | ISO | TBC1D9B (Homo sapiens) | 6480464 | Selenium results in increased expression of TBC1D9B mRNA | CTD | PMID:19244175 | epoxiconazole | decreases expression | EXP | | 6480464 | epoxiconazole results in decreased expression of TBC1D9B mRNA | CTD | PMID:35436446 | ethanol | multiple interactions | EXP | | 6480464 | Ethanol affects the expression of and affects the splicing of TBC1D9B mRNA | CTD | PMID:30319688 | ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of TBC1D9B mRNA | CTD | PMID:30319688 | folic acid | multiple interactions | EXP | | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of TBC1D9B mRNA | CTD | PMID:22206623 | FR900359 | affects phosphorylation | ISO | TBC1D9B (Homo sapiens) | 6480464 | FR900359 affects the phosphorylation of TBC1D9B protein | CTD | PMID:37730182 | indometacin | multiple interactions | ISO | TBC1D9B (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of TBC1D9B mRNA | CTD | PMID:28628672 | inulin | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TBC1D9B mRNA | CTD | PMID:36331819 | ivermectin | decreases expression | ISO | TBC1D9B (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of TBC1D9B protein | CTD | PMID:32959892 | menadione | affects expression | ISO | TBC1D9B (Homo sapiens) | 6480464 | Vitamin K 3 affects the expression of TBC1D9B mRNA | CTD | PMID:20044591 | methoxychlor | affects methylation | ISO | Tbc1d9b (Rattus norvegicus) | 6480464 | Methoxychlor affects the methylation of TBC1D9B gene | CTD | PMID:35440735 | mono(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased expression of TBC1D9B mRNA | CTD | PMID:38113427 | N-methyl-4-phenylpyridinium | increases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of TBC1D9B mRNA | CTD | PMID:22776087 | ozone | multiple interactions | ISO | TBC1D9B (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TBC1D9B mRNA more ... | CTD | PMID:32699268 and PMID:32845096 | perfluorooctane-1-sulfonic acid | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TBC1D9B mRNA and [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TBC1D9B mRNA | CTD | PMID:36331819 | potassium dichromate | increases expression | ISO | TBC1D9B (Homo sapiens) | 6480464 | Potassium Dichromate results in increased expression of TBC1D9B protein | CTD | PMID:23718831 | quercetin | increases phosphorylation | ISO | TBC1D9B (Homo sapiens) | 6480464 | Quercetin results in increased phosphorylation of TBC1D9B protein | CTD | PMID:35688186 | selenium atom | multiple interactions | ISO | TBC1D9B (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of TBC1D9B mRNA | CTD | PMID:19244175 | selenium atom | increases expression | ISO | TBC1D9B (Homo sapiens) | 6480464 | Selenium results in increased expression of TBC1D9B mRNA | CTD | PMID:19244175 | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of TBC1D9B protein | CTD | PMID:29044176 | tungsten | decreases expression | EXP | | 6480464 | Tungsten results in decreased expression of TBC1D9B mRNA | CTD | PMID:30912803 | valproic acid | increases methylation | ISO | TBC1D9B (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of TBC1D9B gene | CTD | PMID:29154799 and PMID:29501571 | valproic acid | affects expression | ISO | TBC1D9B (Homo sapiens) | 6480464 | Valproic Acid affects the expression of TBC1D9B mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | ISO | TBC1D9B (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of TBC1D9B mRNA | CTD | PMID:29154799 and PMID:29501571 | vitamin E | multiple interactions | ISO | TBC1D9B (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of TBC1D9B mRNA | CTD | PMID:19244175 | |